brain natriuretic peptides (BNP) reference values
Last reviewed 06/2021
Reference ranges natriuretic peptides
- Serum natriuretic peptides
- High levels
- BNP > 400 pg/ml (116 pmol/litre) or NTproBNP > 2000 pg/ml (236 pmol/litre)
- BNP > 400 pg/ml (116 pmol/litre) or NTproBNP > 2000 pg/ml (236 pmol/litre)
- Raised levels
- BNP 100-400 pg/ml (29-116 pmol/litre) or NTproBNP 400-2000 pg/ml
(47-236 pmol/litre)
- BNP 100-400 pg/ml (29-116 pmol/litre) or NTproBNP 400-2000 pg/ml
(47-236 pmol/litre)
- Normal levels
- BNP < 100 pg/ml (29 pmol/litre) or NTproBNP < 400 pg/ml (47 pmol/litre)
- High levels
Notes:
- serum natriuretic peptides:
- obesity or treatment with diuretics, angiotensin-converting enzyme (ACE)
inhibitors, beta-blockers, angiotensin II receptor antagonists (ARBs)
and aldosterone antagonists can reduce levels of serum natriuretic peptides
- high levels of serum natriuretic peptides can have causes other than
heart failure (for example, left ventricular hypertrophy, ischaemia, tachycardia,
right ventricular overload, hypoxaemia [including pulmonary embolism],
renal dysfunction [GFR < 60 ml/minute], sepsis, chronic obstructive pulmonary
disease [COPD], diabetes, age > 70 years and cirrhosis of the liver)
- a serum BNP level less than 100 pg/ml (29 pmol/litre) or an NTproBNP
level less than 400 pg/ml (47 pmol/litre) in an untreated patient makes
a diagnosis of heart failure unlikely
- the level of serum natriuretic peptide does not differentiate between heart failure due to left ventricular systolic dysfunction and heart failure with preserved left ventricular ejection fraction
- obesity or treatment with diuretics, angiotensin-converting enzyme (ACE)
inhibitors, beta-blockers, angiotensin II receptor antagonists (ARBs)
and aldosterone antagonists can reduce levels of serum natriuretic peptides
Reference: